Health knowledge made personal
› Share page:

Posts

Sort by: Most recent | Name
SCOTUS Opens Door For FTC, Congress to Stop Collusive Pay-for-Delay Deals by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy FOR IMMEDIATE RELEASE June 18, 2013   Contact: Kathy Melley  Community Catalyst  (617) 275-2861/ (617) 791-0708   kmelley@communitycatalyst.org Statement ... Read on »
Billions on the line for consumers and Medicaid with the coming pay-for-delay decision by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy In the next two weeks, the Supreme Court will likely rule in the FTC v. Actavis case, and decide whether pay-for-delay – when drug companies pay their competitors to not i ... Read on »
STOP PHARMA’S BACK-ROOM DEALS by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy Did you know? Pharmaceutical companies are colluding to keep drug prices high – and taking that money right out of your pocket. Have you faced problems getting t ... Read on »
New Resources to Find Affordable Medications by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy As patients and consumers, we face more and more choices about our health care each year. We all support consumer empowerment in decisions about their care, but consum ... Read on »
Action Alert: Stop the #RxRacket! by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy TAKE ACTION FOR LOWER DRUG COSTS! HELP SPREAD THE WORD Consumer Catalyst has launched a social media campaign to raise awareness about how sketchy ‘Pay-for-Delay’ deal ... Read on »
Paying for Delay – Putting Consumers in the Crosshairs by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy Reposted from the Community catalyst blog…. As we discussed here last week , the U.S. Supreme Court is currently deliberating over whether pharmaceutical companies can ... Read on »
SCOTUS Raises Consumer Impact in Arguments on Delayed Generic Drugs by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy March 25, 2015 Today, the U.S. Supreme Court heard oral arguments in a lawsuit about a drug company’s ability to pay a competitor to keep a generic drug off the market ... Read on »
Arkansas’ Game-Changing Trial on Drug Fraud Could Save Medicaid Program by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy [Also posted on Postscript ] When drugmakers lie to doctors about a drug’s safety or effectiveness, health plans pay more for substandard care, and patients suffer. ... Read on »
Protecting seniors from Abbott’s abuses – the Depakote saga by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy [Also posted on Postscript ] The guilty plea and $1.5 billion settlement by Abbott to resolve their illegal off-label promotion of Depakote revealed a saga of extensiv ... Read on »
Anti-fraud efforts by Attorneys-General and the Department of Justice are reaping billions more... by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy Posted May 29th, 2012 The Affordable Care Act created some desperately needed means to start controlling ever-rising health care costs. Many — like preventive care or ... Read on »
Pricing fraud lawsuit leads to big rewards for Massachusetts by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy Yesterday, the Massachusetts Attorney-General’s office announced a $24 million dollar settlement resulting from an investigation of pricing fraud in state programs by f ... Read on »
Are anti-fraud measures reducing access to needed cancer drugs? by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy During the last few years of recession, the brand-name drug industry has continued to charge higher and higher prices. In 2009, brand-name drug prices rose an average of 9 ... Read on »
Consumers Groups ask FTC to undo CVS – Caremark merger by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy  Harms to competition, and to consumer choice, cost, and privacy cited. Community Catalyst joined Consumer Union, US Pirg, the National Consumer Federation, and NLARx ... Read on »
Sharfstein leaving FDA on right track by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy Here is a blog from our partners at PostScript chronicling  the ground-breaking work by FDA under Dr. Joshua Sharfstein, the departing Deputy Commissioner who lead the age ... Read on »
FTC Chairman: Chances for Pay-for-delay reform are “pretty darned good…” by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy Today’s Pharmalot had a great interview with Jon Liebowitz , the Chairman of the FTC, on the problem of pay-for-delay settlements that prevent consumer access to generic v ... Read on »
Pay-for-delay needs Congressional fix after Court denies hearing by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy A negative court decision before the Second Circuit this week underscores the importance of passing federal legislation to ban ‘pay-for-delay’ settlements in order to pre ... Read on »
Posted today by the PostScri ... by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy Posted today by the PostScript blog at Community Catalyst: New Legislation to Protect and Improve the American Drug Supply Posted on: August 4, 2010; 11:53 ... Read on »
Is the end of pay-for-delay settlements in sight? by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy The last year has been a roller coaster-ride of both successes and set-backs in the fight to eliminate pay-for delay settlements. These multi-million dollar sweetheart dea ... Read on »
GSK troubles continue with Paxil settlement, questions on Avandia panel by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy Billion-dollar settlement of Paxil birth-defect lawsuits Only a week after Glaxo SmithKline (GSK) agreed to pay $460 million to settle over 10,000 personal injury laws ... Read on »
Avandia: A Scandalous Past and an Uncertain Future by Prescription Access Litigation Patient ExpertHealth Maven Posted in: Blog Posts in Healthcare Industry & Policy Following up on last week’s blog discussing the FDA hearing underway to determine the safety of the prescription diabetes drug, Avandia, the FDA advisory review panel conc ... Read on »